Abstract
Background
Posterior scleritis is a potentially blinding inflammatory disorder rarely seen in children. Standard care consists of systemic administration of steroids and immunosuppressants such as methotrexate or ciclosporin A. We describe the case of a young girl suffering from therapy refractory posterior scleritis successfully treated with the tumor necrosis factor (TNF) inhibitor infliximab.
Methods
This study was an interventional case report. The medical chart of a 13-year-old child treated with infliximab (5 mg/kg, 10 applications at a 4–8 week interval) was reviewed for changes of visual acuity, fundoscopy, optic choherence tomography, ultrasound imaging, and adverse events.
Results
Infliximab therapy (5 mg/kg, 10 applications at a 4–8 week interval) led to a long-term remission of posterior scleritis after unsuccessful therapy with high dose prednisolone, methotrexate, and ciclosporin A. To date no side effects have been reported.
Conclusions
Administration of infliximab may be considered under appropriate circumstances to treat children with posterior scleritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McCluskey PJ, Watson PG, Lightman S, Haybittle J, Restori M, Brantley M (1999) Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 106(12):2380–2386
Bernauer W, Büchi ER, Daicker B (1995) Immunopathological finding in posterior scleritis. Int Ophthalmol 18:229–231
Aeberli D, Oertle S et al (2002) Inhibition of TNF pathway: use of infliximab and eternacept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly 132:414–422
Murphy CC, MMedSc et al (2004) Tumor necrosis factor a blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111(2):352–356
Lindstedt EW, Baarsma G, Kuijpers RWAM, van Hagen PM (2005) Anti-TNF-α therapy for sight threatening uveitis. Br J Ophthalmol 89:533–536
Chipczynska B, Gralek M, Klimaczak-Slaczka D, Kanigowska K, Sarti G (2005) Scleritis posterior in child-case report. Klin Oczna 107(1–3):137–139
Woon WH, Stanford MR, Graham EM (1995) Severe idiopathic posterior scleritis in children. Eye 9(Pt 5):570–574
Horo S, Sudharshan S, Biswas J (2006) Recurrent posterior scleritis—report of a case. Ocul Immunol Inflamm 14(1):51–56
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weiss, K., Rieger, R., Keitzer, R. et al. Successful infliximab treatment of posterior scleritis in a 13-year-old child refractory to other immunosuppressive therapy. Graefes Arch Clin Exp Ophthalmol 245, 1735–1737 (2007). https://doi.org/10.1007/s00417-007-0634-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0634-1